These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23281003)

  • 1. In-a-dish: induced pluripotent stem cells as a novel model for human diseases.
    Beltrão-Braga PC; Pignatari GC; Russo FB; Fernandes IR; Muotri AR
    Cytometry A; 2013 Jan; 83(1):11-7. PubMed ID: 23281003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cell for modeling neurological diseases.
    Yung JS; Tam PK; Ngan ES
    Exp Cell Res; 2013 Jan; 319(2):177-84. PubMed ID: 23159386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling epilepsy with pluripotent human cells.
    Muotri AR
    Epilepsy Behav; 2009 Jan; 14 Suppl 1():81-5. PubMed ID: 18845273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo generation of neural tumors from neoplastic pluripotent stem cells models early human pediatric brain tumor formation.
    Werbowetski-Ogilvie TE; Morrison LC; Fiebig-Comyn A; Bhatia M
    Stem Cells; 2012 Mar; 30(3):392-404. PubMed ID: 22213600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of low oxygen on self-renewal and differentiation of embryonic stem cells.
    Millman JR; Tan JH; Colton CK
    Curr Opin Organ Transplant; 2009 Dec; 14(6):694-700. PubMed ID: 19779343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational potential of human embryonic and induced pluripotent stem cells for myocardial repair: insights from experimental models.
    Kong CW; Akar FG; Li RA
    Thromb Haemost; 2010 Jul; 104(1):30-8. PubMed ID: 20539906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploiting pluripotency for therapeutic gain.
    Deng W
    Panminerva Med; 2010 Jun; 52(2):167-73. PubMed ID: 20517198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cells, cancer stem-like cells, and natural products.
    Efferth T
    Planta Med; 2012 Jun; 78(10):935-42. PubMed ID: 22573366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pluripotent stem cells for genetic disease modeling and drug screening.
    Gauthier M; Maury Y; Peschanski M; Martinat C
    Regen Med; 2011 Sep; 6(5):607-22. PubMed ID: 21916596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pluripotent stem cells in drug discovery and predictive toxicology.
    Laustriat D; Gide J; Peschanski M
    Biochem Soc Trans; 2010 Aug; 38(4):1051-7. PubMed ID: 20659002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic differentiation of pluripotent stem cells.
    Loya K; Eggenschwiler R; Ko K; Sgodda M; André F; Bleidissel M; Schöler HR; Cantz T
    Biol Chem; 2009 Oct; 390(10):1047-55. PubMed ID: 19642877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Neurological Disorders with Human Pluripotent Stem Cell-Derived Astrocytes.
    Suga M; Kondo T; Inoue H
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.
    Lemonnier T; Blanchard S; Toli D; Roy E; Bigou S; Froissart R; Rouvet I; Vitry S; Heard JM; Bohl D
    Hum Mol Genet; 2011 Sep; 20(18):3653-66. PubMed ID: 21685203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human disease modeling with induced pluripotent stem cells.
    Trounson A; Shepard KA; DeWitt ND
    Curr Opin Genet Dev; 2012 Oct; 22(5):509-16. PubMed ID: 22868174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology.
    Nikoletopoulou V; Tavernarakis N
    Biotechnol J; 2012 Sep; 7(9):1156-68. PubMed ID: 22890755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?
    Lopes C; Rego AC
    Mol Neurobiol; 2017 Apr; 54(3):1858-1873. PubMed ID: 26892627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.